Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00025896
Status:
COMPLETED
Last Update Posted:
2014-11-13
First Post:
2001-10-31
Brief Title:
Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Glycogenosis 2 |
| Pompe Disease |
| Glycogen Storage Disease Type II |
| Acid Maltase Deficiency Disease |
Keywords: